RT Journal Article
SR Electronic
T1 Genomics yields biological and phenotypic insights into bipolar disorder
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.10.07.23296687
DO 10.1101/2023.10.07.23296687
A1 O’Connell, Kevin S.
A1 Koromina, Maria
A1 van der Veen, Tracey
A1 Boltz, Toni
A1 David, Friederike S.
A1 Kay Yang, Jessica Mei
A1 Lin, Keng-Han
A1 Wang, Xin
A1 Coleman, Jonathan R. I.
A1 Mitchell, Brittany L.
A1 McGrouther, Caroline C.
A1 Rangan, Aaditya V.
A1 Lind, Penelope A.
A1 Koch, Elise
A1 Harder, Arvid
A1 Parker, Nadine
A1 Bendl, Jaroslav
A1 Adorjan, Kristina
A1 Agerbo, Esben
A1 Albani, Diego
A1 Alemany, Silvia
A1 Alliey-Rodriguez, Ney
A1 Als, Thomas D.
A1 Andlauer, Till F. M.
A1 Antoniou, Anastasia
A1 Ask, Helga
A1 Bass, Nicholas
A1 Bauer, Michael
A1 Beins, Eva C.
A1 Bigdeli, Tim B.
A1 Pedersen, Carsten Bøcker
A1 Boks, Marco P.
A1 Børte, Sigrid
A1 Bosch, Rosa
A1 Brum, Murielle
A1 Brumpton, Ben M.
A1 Brunkhorst-Kanaan, Nathalie
A1 Budde, Monika
A1 Bybjerg-Grauholm, Jonas
A1 Byerley, William
A1 Cabana-Domínguez, Judit
A1 Cairns, Murray J.
A1 Carpiniello, Bernardo
A1 Casas, Miquel
A1 Cervantes, Pablo
A1 Chatzinakos, Chris
A1 Chen, Hsi-Chung
A1 Clarence, Tereza
A1 Clarke, Toni-Kim
A1 Claus, Isabelle
A1 Coombes, Brandon
A1 Corfield, Elizabeth C.
A1 Cruceanu, Cristiana
A1 Cuellar-Barboza, Alfredo
A1 Czerski, Piotr M.
A1 Dafnas, Konstantinos
A1 Dale, Anders M.
A1 Dalkner, Nina
A1 Degenhardt, Franziska
A1 DePaulo, J. Raymond
A1 Djurovic, Srdjan
A1 Drange, Ole Kristian
A1 Escott-Price, Valentina
A1 Fanous, Ayman H.
A1 Fellendorf, Frederike T.
A1 Ferrier, I. Nicol
A1 Forty, Liz
A1 Frank, Josef
A1 Frei, Oleksandr
A1 Freimer, Nelson B.
A1 Fullard, John F.
A1 Garnham, Julie
A1 Gizer, Ian R.
A1 Gordon, Scott D.
A1 Gordon-Smith, Katherine
A1 Greenwood, Tiffany A.
A1 Grove, Jakob
A1 Guzman-Parra, José
A1 Ha, Tae Hyon
A1 Hahn, Tim
A1 Haraldsson, Magnus
A1 Hautzinger, Martin
A1 Havdahl, Alexandra
A1 Heilbronner, Urs
A1 Hellgren, Dennis
A1 Herms, Stefan
A1 Hickie, Ian B.
A1 Hoffmann, Per
A1 Holmans, Peter A.
A1 Huang, Ming-Chyi
A1 Ikeda, Masashi
A1 Jamain, Stéphane
A1 Johnson, Jessica S.
A1 Jonsson, Lina
A1 Kalman, Janos L.
A1 Kamatani, Yoichiro
A1 Kennedy, James L.
A1 Kim, Euitae
A1 Kim, Jaeyoung
A1 Kittel-Schneider, Sarah
A1 Knowles, James A.
A1 Kogevinas, Manolis
A1 Kranz, Thorsten M.
A1 Krebs, Kristi
A1 Kushner, Steven A.
A1 Lavebratt, Catharina
A1 Lawrence, Jacob
A1 Leber, Markus
A1 Lee, Heon-Jeong
A1 Liao, Calwing
A1 Lucae, Susanne
A1 Lundberg, Martin
A1 MacIntyre, Donald J.
A1 Maier, Wolfgang
A1 Maihofer, Adam X.
A1 Malaspina, Dolores
A1 Manchia, Mirko
A1 Maratou, Eirini
A1 Martinsson, Lina
A1 Mattheisen, Manuel
A1 McGregor, Nathaniel W.
A1 McInnis, Melvin G.
A1 McKay, James D.
A1 Medeiros, Helena
A1 Meyer-Lindenberg, Andreas
A1 Millischer, Vincent
A1 Morris, Derek W.
A1 Moutsatsou, Paraskevi
A1 Mühleisen, Thomas W.
A1 O’Donovan, Claire
A1 Olsen, Catherine M.
A1 Panagiotaropoulou, Georgia
A1 Papiol, Sergi
A1 Pardiñas, Antonio F.
A1 Park, Hye Youn
A1 Perry, Amy
A1 Pfennig, Andrea
A1 Pisanu, Claudia
A1 Potash, James B.
A1 Quested, Digby
A1 Rapaport, Mark H.
A1 Regeer, Eline J.
A1 Rice, John P.
A1 Rivera, Margarita
A1 Schulte, Eva C.
A1 Senner, Fanny
A1 Shadrin, Alexey
A1 Shilling, Paul D.
A1 Sigurdsson, Engilbert
A1 Sindermann, Lisa
A1 Sirignano, Lea
A1 Siskind, Dan
A1 Slaney, Claire
A1 Sloofman, Laura G.
A1 Smeland, Olav B.
A1 Smith, Daniel J.
A1 Sobell, Janet L.
A1 Artigas, Maria Soler
A1 Stein, Dan J.
A1 Stein, Frederike
A1 Su, Mei-Hsin
A1 Sung, Heejong
A1 Świątkowska, Beata
A1 Terao, Chikashi
A1 Tesfaye, Markos
A1 Tesli, Martin
A1 Thorgeirsson, Thorgeir E.
A1 Thorp, Jackson G.
A1 Toma, Claudio
A1 Tondo, Leonardo
A1 Tooney, Paul A.
A1 Tsai, Shih-Jen
A1 Tsermpini, Evangelia Eirini
A1 Vawter, Marquis P.
A1 Vedder, Helmut
A1 Vreeker, Annabel
A1 Walters, James T. R.
A1 Winsvold, Bendik S.
A1 Witt, Stephanie H.
A1 Won, Hong-Hee
A1 Ye, Robert
A1 Young, Allan H.
A1 Zandi, Peter P.
A1 Zillich, Lea
A1 23andMe Research Team
A1 Estonian Biobank research team
A1 Genoplan Research Team
A1 HUNT All-In Psychiatry
A1 PGC-FG Single cell working group
A1 Genomic Psychiatry Cohort (GPC) Investigators
A1 Adolfsson, Rolf
A1 Alda, Martin
A1 Alfredsson, Lars
A1 Backlund, Lena
A1 Baune, Bernhard T.
A1 Bellivier, Frank
A1 Bengesser, Susanne
A1 Berrettini, Wade H.
A1 Biernacka, Joanna M.
A1 Boehnke, Michael
A1 Børglum, Anders D.
A1 Breen, Gerome
A1 Carr, Vaughan J.
A1 Catts, Stanley
A1 Cichon, Sven
A1 Corvin, Aiden
A1 Craddock, Nicholas
A1 Dannlowski, Udo
A1 Dikeos, Dimitris
A1 Etain, Bruno
A1 Ferentinos, Panagiotis
A1 Frye, Mark
A1 Fullerton, Janice M.
A1 Gawlik, Micha
A1 Gershon, Elliot S.
A1 Goes, Fernando S.
A1 Green, Melissa J.
A1 Grigoroiu-Serbanescu, Maria
A1 Hauser, Joanna
A1 Henskens, Frans A.
A1 Hjerling-Leffler, Jens
A1 Hougaard, David M.
A1 Hveem, Kristian
A1 Iwata, Nakao
A1 Jones, Ian
A1 Jones, Lisa A.
A1 Kahn, René S.
A1 Kelsoe, John R.
A1 Kircher, Tilo
A1 Kirov, George
A1 Kuo, Po-Hsiu
A1 Landén, Mikael
A1 Leboyer, Marion
A1 Li, Qingqin S.
A1 Lissowska, Jolanta
A1 Lochner, Christine
A1 Loughland, Carmel
A1 Luykx, Jurjen J.
A1 Martin, Nicholas G.
A1 Mathews, Carol A.
A1 Mayoral, Fermin
A1 McElroy, Susan L.
A1 McIntosh, Andrew M.
A1 McMahon, Francis J.
A1 Medland, Sarah E.
A1 Melle, Ingrid
A1 Milani, Lili
A1 Mitchell, Philip B.
A1 Morken, Gunnar
A1 Mors, Ole
A1 Mortensen, Preben Bo
A1 Müller-Myhsok, Bertram
A1 Myers, Richard M.
A1 Myung, Woojae
A1 Neale, Benjamin M.
A1 Nievergelt, Caroline M.
A1 Nordentoft, Merete
A1 Nöthen, Markus M.
A1 Nurnberger, John I.
A1 O’Donovan, Michael C.
A1 Oedegaard, Ketil J.
A1 Olsson, Tomas
A1 Owen, Michael J.
A1 Paciga, Sara A.
A1 Pantelis, Christos
A1 Pato, Carlos N.
A1 Pato, Michele T.
A1 Patrinos, George P.
A1 Pawlak, Joanna M.
A1 Ramos-Quiroga, Josep Antoni
A1 Reif, Andreas
A1 Reininghaus, Eva Z.
A1 Ribasés, Marta
A1 Rietschel, Marcella
A1 Ripke, Stephan
A1 Rouleau, Guy A.
A1 Roussos, Panos
A1 Saito, Takeo
A1 Schall, Ulrich
A1 Schalling, Martin
A1 Schofield, Peter R.
A1 Schulze, Thomas G.
A1 Scott, Laura J.
A1 Scott, Rodney J.
A1 Serretti, Alessandro
A1 Smoller, Jordan W.
A1 Squassina, Alessio
A1 Stahl, Eli A.
A1 Stefansson, Hreinn
A1 Stefansson, Kari
A1 Stordal, Eystein
A1 Streit, Fabian
A1 Sullivan, Patrick F.
A1 Turecki, Gustavo
A1 Vaaler, Arne E.
A1 Vieta, Eduard
A1 Vincent, John B.
A1 Waldman, Irwin D.
A1 Weickert, Cynthia S.
A1 Weickert, Thomas W.
A1 Werge, Thomas
A1 Whiteman, David C.
A1 Zwart, John-Anker
A1 Edenberg, Howard J.
A1 McQuillin, Andrew
A1 Forstner, Andreas J.
A1 Mullins, Niamh
A1 Di Florio, Arianna
A1 Ophoff, Roel A.
A1 Andreassen, Ole A.
A1 the Bipolar Disorder Working Group of the Psychiatric Genomics Consortium
YR 2024
UL http://medrxiv.org/content/early/2024/08/27/2023.10.07.23296687.abstract
AB Bipolar disorder (BD) is a leading contributor to the global burden of disease1. Despite high heritability (60-80%), the majority of the underlying genetic determinants remain unknown2. We analysed data from participants of European, East Asian, African American and Latino ancestries (n=158,036 BD cases, 2.8 million controls), combining Clinical, Community, and Self-reported samples. We identified 298 genome-wide significant loci in the multi-ancestry meta-analysis, a 4-fold increase over previous findings3, and identified a novel ancestry-specific association in the East Asian cohort. Integrating results from fine-mapping and other variant-to-gene mapping approaches identified 36 credible genes in the aetiology of BD. Genes prioritised through fine-mapping were enriched for ultra-rare damaging missense and protein-truncating variations in BD cases4, highlighting convergence of common and rare variant signals. We report differences in genetic architecture of BD depending on the source of patient ascertainment and on BD-subtype (BDI and BDII). Several analyses implicate specific cell types in BD pathophysiology, including GABAergic interneurons and medium spiny neurons. Together, these analyses provide novel insights into the genetic architecture and biological underpinnings of BD.Competing Interest StatementT.E.T., H.S. and K.S. are employed by deCODE Genetics/Amgen. E.A.S. is an employee of Regeneron Genetics Center and owns stocks of Regeneron Pharmaceutical Co. KH.L. and X.W. are employed by 23andMe Inc. Multiple additional authors work for pharmaceutical or biotechnology companies in a manner directly analogous to academic coauthors and collaborators. A.H.Y. has given paid lectures and served on advisory boards relating to drugs used in affective and related disorders for several companies (AstraZeneca, Eli Lilly, Lundbeck, Sunovion, Servier, Livanova, Janssen, Allergan, Bionomics and Sumitomo Dainippon Pharma), was Lead Investigator for Embolden Study (AstraZeneca), BCI Neuroplasticity study and Aripiprazole Mania Study, and is an investigator for Janssen, Lundbeck, Livanova and Compass. J.I.N. is an investigator for Janssen. P.F.S. reports the following potentially competing financial interests: Neumora Therapeutics (advisory committee and shareholder). G. Breen reports consultancy and speaker fees from Eli Lilly and Illumina and grant funding from Eli Lilly. M. Landen has received speaker fees from Lundbeck. O.A.A. has served as a speaker for Janssen, Lundbeck, and Sunovion and as a consultant for Cortechs.ai. A.M.D. is a founder of and holds equity interest in CorTechs Labs and serves on its scientific advisory board; he is a member of the scientific advisory board of Human Longevity and the Mohn Medical Imaging and Visualization Center (Bergen, Norway); and he has received research funding from General Electric Healthcare. E.V. has received grants and served as a consultant, advisor or CME speaker for the following entities: AB Biotics, Abbott, Allergan, Angelini, AstraZeneca, Bristol Myers Squibb, Dainippon Sumitomo Pharma, Farmindustria, Ferrer, Forest Research Institute, Gedeon Richter, GlaxoSmithKline, Janssen, Lundbeck, Otsuka, Pfizer, Roche, SAGE, Sanofi Aventis, Servier, Shire, Sunovion, Takeda, the Brain and Behaviour Foundation, the Catalan Government (AGAUR and PERIS), the Spanish Ministry of Science, Innovation, and Universities (AES and CIBERSAM), the Seventh European Framework Programme and Horizon 2020 and the Stanley Medical Research Institute. S.K.S. received authors, speakers and consultant honoraria from Janssen, Medice Arzneimittel Putter GmbH and Takeda outside of the current work A.S. is or has been a consultant/speaker for: Abbott, Abbvie, Angelini, AstraZeneca, Clinical Data, Boheringer, Bristol Myers Squibb, Eli Lilly, GlaxoSmithKline, Innovapharma, Italfarmaco, Janssen, Lundbeck, Naurex, Pfizer, Polifarma, Sanofi, Servier. J.R.D. has served as an unpaid consultant to Myriad Neuroscience (formerly Assurex Health) in 2017 and 2019 and owns stock in CVS Health. B.M.N. is a member of the scientific advisory board at Deep Genomics and consultant for Camp4 Therapeutics, Takeda Pharmaceutical and Biogen. B.C.L, J.W.K, Y.K.L, J.H.K, M.J.C, and D.J.K are employed by Genoplan inc. I.B.H. is the Co-Director of Health and Policy at the Brain and Mind Centre (BMC) University of Sydney. The BMC operates an early-intervention youth services at Camperdown under contract to Headspace. He is the Chief Scientific Advisor to, and a 3.2% equity shareholder in, InnoWell Pty Ltd. InnoWell was formed by the University of Sydney (45% equity) and PwC (Australia; 45% equity) to deliver the $30 M Australian Government funded Project Synergy (2017to 2020; a three year program for the transformation of mental health services) and to lead transformation of mental health services internationally through the use of innovative technologies. MJO and MCOD have received funding from Takeda Pharmaceuticals and Akrivia Health outside the scope of the current work. PBM has received remuneration from Janssen (Australia) and Sanofi (Hangzhou) for lectures or advisory board membership. All other authors declare no financial interests or potential conflicts of interest.Funding StatementThe PGC has received major funding from the US National Institute of Mental Health (PGC4: R01 MH124839; PGC3: U01 MH109528; PGC2: U01 MH094421; PGC1: U01 MH085520). Statistical analyses were carried out on the NL Genetic Cluster Computer (http://www.geneticcluster.org) hosted by SURFsara. Full details of all funding sources are included in the Supplementary Note.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Boards that provided approval or exemption for each cohort are given in Supplementary Table 1.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.Yes